The purpose of the study is to test the efficacy of ATNC05 in the treatment of Atypical Facial Pain (AFP), also known as Persistent Idiopathic Facial Pain (PIFP). This research project targets patients with chronic constant facial pain and excludes patients with primarily paroxysmal pain.

Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain

Phase II Double Blind, Randomized, Placebo Controlled, Safety and Efficacy Study of ATNC05 in Patients With Atypical Facial Pain With an Open-Label Extension Phase for Nonresponders

Treatment Trials

Focus your search

Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain

Description

Conditions